CVRx, Inc. (CVRX) vs Pulmonx Corporation (LUNG)
CVRx, Inc. and Pulmonx Corporation are both Medical Devices companies. Pulmonx Corporation is the larger, with a market value of $81.6M against $67.4M — 1.2× the size. CVRx, Inc. grew revenue faster over the last twelve months: 12.0% against −3.43%. Pulmonx Corporation has the higher net margin (−55.0% vs −84.9%) and the higher return on invested capital (−141.0% vs −218.1%). Across the 18 metrics below, Pulmonx Corporation leads on 12 and CVRx, Inc. on 6.
Valuation
Profitability
| Metric | CVRX | LUNG | Medical Devices median |
|---|---|---|---|
| Gross margin | 86.92% | 77.06% | 56.01% |
| Operating margin | (79.49%) | (52.96%) | (15.03%) |
| Net margin | (84.93%) | (55.03%) | (20.40%) |
| Free cash flow margin | (67.09%) | (35.07%) | (7.24%) |
| Return on equity | (133.44%) | (88.87%) | (15.32%) |
| Return on assets | (49.06%) | (36.74%) | (19.72%) |
| Return on invested capital | (218.09%) | (141.03%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack